retatrutide clinical study New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide Weight Loss Results:Trial Data

Healthy Body Function - Promote optimal body function and support your gut and body health without the harsh chemicals, while also reaching your fitness goals

The best available data show that both semaglutide and tirzepatide reduce fat mass substantially and lean mass to a lesser extent, roughly in proportion to total weight lost

Post-purchase independent testing Even with solid pre-purchase documentation, independent verification of received material is essential for any bulk order

New evidence suggests trizepatide (Zepound/Mounjaro) produces the largest weight loss on average, outperforming semaglutide in trials